- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
A Novel Inherited Form of Diabetes and Obesity Discovered
Scientists at the Imperial College London have identified a genetic link to obesity and diabetes in an extremely obese woman and her family members.
Scientists at the Imperial College London have identified a genetic link to obesity and diabetes in an extremely obese woman and her family members. The results have led the scientists to believe that obesity can be inherited.
On sequencing the DNA of this woman and her family, researchers discovered that a homozygous deletion prevented her body from synthesizing the protein carboxypeptidase-E (CPE). CPE is important in the proper processing of a number of hormones and neurotransmitters that regulate appetite, insulin, and other hormones important in the reproductive system, and lack of expression resulted in the woman being obese, suffering from type 2 diabetes mellitus, and intellectually challenged.
Professor Alex Blakemore, lead author on the study that was published in the journal PLOS One, said: "There are now an increasing number of single-gene causes of obesity and diabetes known. We don't know how many more have yet to be discovered, or what proportion of the severely obese people in our population have these diseases - it is not possible to tell just by looking."
Read more at EurekAlert!: http://bit.ly/1IsXRUT
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More
